These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 29274741)

  • 1. A novel therapeutic approach for treatment of catamenial epilepsy.
    Joshi S; Sun H; Rajasekaran K; Williamson J; Perez-Reyes E; Kapur J
    Neurobiol Dis; 2018 Mar; 111():127-137. PubMed ID: 29274741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A mouse kindling model of perimenstrual catamenial epilepsy.
    Reddy DS; Gould J; Gangisetty O
    J Pharmacol Exp Ther; 2012 Jun; 341(3):784-93. PubMed ID: 22434675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurosteroid regulation of GABA
    Joshi S; Kapur J
    Brain Res; 2019 Jan; 1703():31-40. PubMed ID: 29481795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrous cycle regulation of extrasynaptic δ-containing GABA(A) receptor-mediated tonic inhibition and limbic epileptogenesis.
    Wu X; Gangisetty O; Carver CM; Reddy DS
    J Pharmacol Exp Ther; 2013 Jul; 346(1):146-60. PubMed ID: 23667248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progesterone modulates neuronal excitability bidirectionally.
    Kapur J; Joshi S
    Neurosci Lett; 2021 Jan; 744():135619. PubMed ID: 33421486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurosteroid withdrawal model of perimenstrual catamenial epilepsy.
    Reddy DS; Kim HY; Rogawski MA
    Epilepsia; 2001 Mar; 42(3):328-36. PubMed ID: 11442149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurosteroid replacement therapy for catamenial epilepsy.
    Reddy DS; Rogawski MA
    Neurotherapeutics; 2009 Apr; 6(2):392-401. PubMed ID: 19332335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatments for seizures in catamenial (menstrual-related) epilepsy.
    Maguire MJ; Nevitt SJ
    Cochrane Database Syst Rev; 2021 Sep; 9(9):CD013225. PubMed ID: 34528245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Catamenial epilepsy: Update on prevalence, pathophysiology and treatment from the findings of the NIH Progesterone Treatment Trial.
    Herzog AG
    Seizure; 2015 May; 28():18-25. PubMed ID: 25770028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced anticonvulsant activity of neuroactive steroids in a rat model of catamenial epilepsy.
    Reddy DS; Rogawski MA
    Epilepsia; 2001 Mar; 42(3):337-44. PubMed ID: 11442150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacology of catamenial epilepsy.
    Reddy DS
    Methods Find Exp Clin Pharmacol; 2004 Sep; 26(7):547-61. PubMed ID: 15538544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of neurosteroids in catamenial epilepsy.
    Reddy DS
    Epilepsy Res; 2004 Dec; 62(2-3):99-118. PubMed ID: 15579299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Limbic progesterone receptor activity enhances neuronal excitability and seizures.
    Shiono S; Sun H; Batabyal T; Labuz A; Williamson J; Kapur J; Joshi S
    Epilepsia; 2021 Aug; 62(8):1946-1959. PubMed ID: 34164810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurosteroid withdrawal regulates GABA-A receptor α4-subunit expression and seizure susceptibility by activation of progesterone receptor-independent early growth response factor-3 pathway.
    Gangisetty O; Reddy DS
    Neuroscience; 2010 Oct; 170(3):865-80. PubMed ID: 20670676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced anticonvulsant activity of ganaxolone after neurosteroid withdrawal in a rat model of catamenial epilepsy.
    Reddy DS; Rogawski MA
    J Pharmacol Exp Ther; 2000 Sep; 294(3):909-15. PubMed ID: 10945840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of neurosteroids in the pathophysiology and treatment of catamenial epilepsy.
    Reddy DS
    Epilepsy Res; 2009 Jul; 85(1):1-30. PubMed ID: 19406620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatments for seizures in catamenial (menstrual-related) epilepsy.
    Maguire MJ; Nevitt SJ
    Cochrane Database Syst Rev; 2019 Oct; 10(10):CD013225. PubMed ID: 31608992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progesterone vs placebo therapy for women with epilepsy: A randomized clinical trial.
    Herzog AG; Fowler KM; Smithson SD; Kalayjian LA; Heck CN; Sperling MR; Liporace JD; Harden CL; Dworetzky BA; Pennell PB; Massaro JM;
    Neurology; 2012 Jun; 78(24):1959-66. PubMed ID: 22649214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Three patterns of catamenial epilepsy.
    Herzog AG; Klein P; Ransil BJ
    Epilepsia; 1997 Oct; 38(10):1082-8. PubMed ID: 9579954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroendocrine aspects of catamenial epilepsy.
    Reddy DS
    Horm Behav; 2013 Feb; 63(2):254-66. PubMed ID: 22579656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.